Literature DB >> 8030244

Single amino acid changes in the S2 subunit of the MHV surface glycoprotein confer resistance to neutralization by S1 subunit-specific monoclonal antibody.

B Grosse1, S G Siddell.   

Abstract

We have isolated 10 monoclonal-antibody-resistant variants (MAR variants) of the murine hepatitis virus (MHV) by selection with a neutralizing monoclonal antibody that binds to the S1 subunit of the surface glycoprotein (MAb 11F, E. Routledge et al., J. Virol. 65, 254-262, 1991). The variant viruses escape neutralization and are able to mediate membrane fusion in the presence of high concentrations of antibody. Sequence analysis of the variant S protein genes showed that they are not mutated in the codons for the amino acids that bind MAb 11F (positions 33 to 40). Instead, they have mutations that encode single amino acid changes in the S2 subunit of the protein (positions 1109, 1110, and 1116). These amino acid substitutions are conservative. Using a T7/vaccinia virus system, we have confirmed that each of the S2 subunit substitutions is able to confer the MAR phenotype on transiently expressed S proteins. The indirect immunoprecipitation of metabolically labeled S protein from cell lysates of MHV- or MAR variant-infected cells shows that the MAR-variant S proteins no longer bind MAb 11F, although they are still bound by a large panel of monoclonal antibodies that recognize many different discontinuous and linear determinants on both the S1 and S2 subunits of the protein. These data provide new insights into the interaction between defined regions of the S1 and S2 subunits of the MHV S protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8030244     DOI: 10.1006/viro.1994.1403

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

1.  Analysis of the serotype-specific epitopes of avian infectious bronchitis virus strains Ark99 and Mass41.

Authors:  W Jia; X Wang; C R Parrish; S A Naqi
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

2.  A single amino acid change within antigenic domain II of the spike protein of bovine coronavirus confers resistance to virus neutralization.

Authors:  D Yoo; D Deregt
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

3.  Infectious bronchitis virus S2 gene sequence variability may affect S1 subunit specific antibody binding.

Authors:  S A Callison; M W Jackwood; D A Hilt
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

4.  The function of the spike protein of mouse hepatitis virus strain A59 can be studied on virus-like particles: cleavage is not required for infectivity.

Authors:  E C Bos; W Luytjes; W J Spaan
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor-resistant mutants.

Authors:  K Saeki; N Ohtsuka; F Taguchi
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding.

Authors:  F Taguchi
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 7.  Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.

Authors:  Susan R Weiss; Sonia Navas-Martin
Journal:  Microbiol Mol Biol Rev       Date:  2005-12       Impact factor: 11.056

8.  Variations in disparate regions of the murine coronavirus spike protein impact the initiation of membrane fusion.

Authors:  D K Krueger; S M Kelly; D N Lewicki; R Ruffolo; T M Gallagher
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

9.  Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51 encode determinants of host range expansion.

Authors:  Willie C McRoy; Ralph S Baric
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

10.  Role of spike protein endodomains in regulating coronavirus entry.

Authors:  Ana Shulla; Tom Gallagher
Journal:  J Biol Chem       Date:  2009-09-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.